Crossmark

Epigenetic remodeling in pulmonary arterial hypertension: metabolic regulation and therapeutic opportunities

Published Online: 2026-09-03

Authors

Kucheriava, Maryna

Hadri, Lahouaria

Bisserier, Malik https://orcid.org/0000-0001-8826-4649
Funding

Funding for this research was provided by:

American Heart Association (23TPA1061690)

American Heart Association (24CDA1269532)

American Lung Association (1056600)

National Heart, Lung, and Blood Institute (R01HL172043)

National Heart, Lung, and Blood Institute (K01HL159038-01A1)

National Center for Advancing Translational Sciences (R03TR00467)

American Thoracic Society (23-24U1)
License Information

Text and Data Mining valid from 2026-09-03

Accepted Manuscript valid from 2026-09-03
More Information

Article History

Received: 15 July 2026

Accepted: 27 August 2026

First Online: 3 September 2026

Declarations

Ethics approval and consent to participate: Not applicable, as this study did not involve human participants or animal subjects.

Consent for publication: Not applicable, as this manuscript does not include any individual data that requires consent.

Competing interests: The authors declare no competing interests.

Document is current